Literature DB >> 27697646

Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action.

Prachi Gupta1, Manju Bala1, Sanjeev Gupta1, Anita Dua1, Rajesh Dabur2, Elisha Injeti3, Ashwani Mittal4.   

Abstract

An increasing array of anti-diabetic drugs are available today, yet Type-2 diabetes mellitus (T2DM) - remains a life threatening disease, causing high mortality and morbidity in developing and developed countries. As of now, no effective therapy is available for the complete eradication/cure of diabetes and its associated complications. Therefore, it is time to re-think and revisit molecular pathways and targets of each existing drug in order to identify multiple targets from different signaling pathways that may be manipulated simultaneously to treat or manage T2DM effectively. Bearing this goal in mind, the article reviews the mechanisms of action of available anti-diabetic drugs with in-depth mechanistic analysis of each therapy. The conventional and herbal strategies are analysed and compared for their benefits and the associated possible side effects. This critical information is necessary not only for the development of better, novel and potent anti-diabetic therapy in future but also for best possible combinational therapies and strategies with the available drugs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acarbose (PubChem CID: 41774); Alogliptin (PubChem CID: 11450633); Anti-diabetic drugs; Canagliflozin (PubChem CID: 24812758); Dapagliflozin (PubChem CID: 9887712); Dipeptidyl peptidase-4 inhibitors; Exenatide (PubChem CID: 56927919); Gliclazide (PubChem CID: 3475); Glimepiride (PubChem CID: 3476); Glyburide (PubChem CID: 3488); Linagliptin (PubChem CID: 10096344); Liraglutide (PubChem CID: 16134956); Lixisenatide (PubChem CID: 90472060); Metformin; Metformin (PubChem CID: 4091); Miglitol (PubChem CID: 441314); Nateglinide (PubChem CID: 5311309); Phlorizin (PubChem CID: 6072); Phyto-drugs; Pioglitazone (PubChem CID: 4829); Pramlintide (PubChem CID: 16132446); Repaglinide (PubChem CID: 65981); Resveratrol (PubChem CID: 91745415); Rosiglitazone (PubChem CID: 77999); SGLT2; Saxagliptin (PubChem CID: 11243969); Sitagliptin (PubChem CID: 4369359); Sulfonylureas; Taspoglutide (PubChem CID: 56842233); Teneligliptin (PubChem CID: 11949652); Thiazolidinediones; Tolbutamide (PubChem CID: 5505); Type 2 diabetes mellitus; Vildagliptin (PubChem CID: 6918537); Voglibose (PubChem CID: 444020); miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27697646     DOI: 10.1016/j.phrs.2016.09.029

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  12 in total

Review 1.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

2.  Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus.

Authors:  Rensong Huang; Meng Zhang; Yu Tong; Yaran Teng; Hui Li; Wei Wu
Journal:  Front Nutr       Date:  2022-04-27

Review 3.  Carbotoxicity-Noxious Effects of Carbohydrates.

Authors:  Guido Kroemer; Carlos López-Otín; Frank Madeo; Rafael de Cabo
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

4.  A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes.

Authors:  Soo-Hyun Park; Ui-Jin Bae; Eun-Kyung Choi; Su-Jin Jung; Sung-Hyen Lee; Jae-Heon Yang; You-Suk Kim; Do-Youn Jeong; Hyun-Ju Kim; Byung-Hyun Park; Soo-Wan Chae
Journal:  BMC Complement Med Ther       Date:  2020-07-06

Review 5.  Bioactive Metabolites from Marine Algae as Potent Pharmacophores against Oxidative Stress-Associated Human Diseases: A Comprehensive Review.

Authors:  Biswajita Pradhan; Rabindra Nayak; Srimanta Patra; Bimal Prasad Jit; Andrea Ragusa; Mrutyunjay Jena
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

6.  The Efficacy of Fenofibrate in Addition to Atorvastatin in Patients of Type II Diabetes Mellitus.

Authors:  Muhammad Qasim; Abroo Bahadur; Shafi Ullah Khan; Adnan Rahman; Aqil Noor; Maaz Zafar; Kiran Abbas
Journal:  Cureus       Date:  2022-03-04

7.  Effect of Co-Administration of Panax ginseng and Brassica oleracea on Postmenopausal Osteoporosis in Ovariectomized Mice.

Authors:  In Soon Kang; Taiwo Samuel Agidigbi; Young Min Kwon; Dong-Gyu Kim; Rang Ie Kim; Gyo In; Mi-Hyang Lee; Chaekyun Kim
Journal:  Nutrients       Date:  2020-08-12       Impact factor: 5.717

8.  In Vitro Antidiabetic Activity and Mechanism of Action of Brachylaena elliptica (Thunb.) DC.

Authors:  Idowu Jonas Sagbo; Maryna van de Venter; Trevor Koekemoer; Graeme Bradley
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-04       Impact factor: 2.629

9.  Synthesis and inhibitory activity of N-acetylpyrrolidine derivatives on α-glucosidase and α-amylase.

Authors:  Sompong Sansenya; Chankan Winyakul; Kesinee Nanok; Waya S Phutdhawong
Journal:  Res Pharm Sci       Date:  2020-02-20

10.  Effect of a Dual PPAR α/γ agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial.

Authors:  Nimisha Jain; Shobhit Bhansali; Anura V Kurpad; Meredith Hawkins; Akhilesh Sharma; Sandeep Kaur; Ashu Rastogi; Anil Bhansali
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.